SARS-CoV-2 variants mediated tissue-specific metabolic reprogramming determines the disease pathophysiology in a hamster model
Brain, Behavior, and Immunity · 2025
DOI: 10.1016/j.bbi.2024.10.032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, Behavior, and Immunity, 2025. Verfasst von Urvinder Kaur Sardarni und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Disease Models, Animal, Gastrointestinal Microbiome. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, University of Iowa, National Institute on Drug Abuse.
Abstract (Originalsprache)
Despite significant effort, a clear understanding of host tissue-specific responses and their implications for immunopathogenicity against the severe acute respiratory syndrome coronavirus2 (SARS-CoV-2) variant infection has remained poorly defined. To shed light on the interaction between tissues and SARS-CoV-2 variants, we sought to characterize the complex relationship among acute multisystem manifestations, dysbiosis of the gut microbiota, and the resulting implications for SARS-CoV-2 variant-specific immunopathogenesis in the Golden Syrian Hamster (GSH) model using multi-omics approaches. Our investigation revealed the presence of increased SARS-CoV-2 genomic RNA in diverse tissues of delta-infected GSH compared to the omicron variant. Multi-omics analyses uncovered distinctive metabolic responses between the delta and omicron variants, with the former demonstrating dysregulation in synaptic transmission proteins associated with neurocognitive disorders. Additionally, delta-infected GSH exhibited an altered fecal microbiota composition, marked by increased inflammation-associated taxa and reduced commensal bacteria compared to the omicron variant. These findings underscore the SARS-CoV-2-mediated tissue insult, characterized by modified host metabolites, neurological protein dysregulation, and gut dysbiosis, highlighting the compromised gut-lung-brain axis during acute infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA.
- The Systems Virology Laboratory, Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, ANA Futura, Campus Flemingsberg, Stockholm, Sweden.
- Antiviral Pharmacology Laboratory, Department of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198, USA.
- Division of Chemistry I, Department of Medical Biochemistry & Biophysics, Karolinska Institutet, Stockholm, Sweden.
- The Systems Virology Laboratory, Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, ANA Futura, Campus Flemingsberg, Stockholm, Sweden. Electronic address: ujjwal.neogi@ki.se.
- Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA. Electronic address: sid.byrareddy@unmc.edu.
Förderung
- NIDA NIH HHS
- University of Iowa
- National Institute on Drug Abuse
- Vetenskapsrådet
- University of Nebraska Medical Center
- Karolinska Institutet
- Roy J. and Lucille A. Carver College of Medicine, University of Iowa
- University of Nebraska-Lincoln
Zitieren
APA
Kaur Sardarni, U., Ambikan, A. T., Acharya, A., Johnson, S. D., Avedissian, S. N., Végvári, Á., Neogi, U., & Byrareddy, S. N. (2025). SARS-CoV-2 variants mediated tissue-specific metabolic reprogramming determines the disease pathophysiology in a hamster model. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2024.10.032
Vancouver
Kaur Sardarni U, Ambikan AT, Acharya A, Johnson SD, Avedissian SN, Végvári Á, et al. SARS-CoV-2 variants mediated tissue-specific metabolic reprogramming determines the disease pathophysiology in a hamster model. Brain, Behavior, and Immunity. 2025. doi:10.1016/j.bbi.2024.10.032
BibTeX
@article{KaurSardarni2025,
author = {Kaur Sardarni, Urvinder and Ambikan, Anoop T and Acharya, Arpan and Johnson, Samuel D and Avedissian, Sean N and Végvári, Ákos and Neogi, Ujjwal and Byrareddy, Siddappa N},
title = {SARS-CoV-2 variants mediated tissue-specific metabolic reprogramming determines the disease pathophysiology in a hamster model},
journal = {Brain, Behavior, and Immunity},
year = {2025},
doi = {10.1016/j.bbi.2024.10.032}
}
EUVIMED